DY, C., WL, M., & YS, L. (2021). Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press.
Cita Chicago Style (17a ed.)DY, Chang, Ma WL, y Lu YS. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
Cita MLA (8a ed.)DY, Chang, et al. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.